为什么不看李蓓的5年业绩？

Core Viewpoint - The article discusses the performance of a fund called "半夏" (Banxia) and addresses criticisms from detractors who focus on a three-year performance window, which is the weakest period for the fund. The author emphasizes that over different time frames, the fund has shown strong performance, particularly in the last year, and calls out the tactics of critics who distort data to undermine the fund's reputation [1][2]. Performance Analysis - Over a one-year period, the "半夏平衡" (Banxia Balanced) fund has outperformed the CSI 300 Index by over 15% [1]. - In a five-year performance ranking, "半夏平衡" ranks in the top third among its peers, specifically 6th out of 19 macro strategy products with over 5 billion in assets under management [1]. - The fund's flagship products have recently reached new highs, maintaining stability even during market corrections [2]. Criticism and Response - The article highlights that critics selectively use a three-year performance window to attack the fund, which has shown a slight loss during that period but has since rebounded [2]. - The author accuses a specific individual, referred to as "梁博士" (Dr. Liang), of using unethical tactics to gain attention by disparaging the fund [3][4]. - The author expresses frustration over the continued negative marketing tactics employed by critics, urging them to cease such activities [8][9]. Future Outlook - The author remains confident in the fund's future performance, asserting that it will outperform competitors due to superior intelligence and integrity [6]. - A call for mutual respect and focus on respective business operations is made, suggesting that performance will ultimately speak for itself in two years [10].